总说「新四联」，达格列净、建平列净到底该怎么用？

sodium-glucose co-transporter 2 inhibitor dapagliflozin on morbidity and mortality in patients with heart failure and reduced left ventricular ejection fraction (DAPA-HF). Eur J Heart Fail. 2019;21(5):665-675. doi:10.1002/ejhf.1432.

2. Packer M, Butler J, Filippatos GS, et al. Evaluation of the effect of sodium-glucose co-transporter 2 inhibition with empagliflozin on morbidity and mortality of patients with chronic heart failure and a reduced ejection fraction: rationale for and design of the EMPEROR-Reduced trial. Eur J Heart Fail. 2019;21(10):1270-1278. doi:10.1002/ejhf.1536.

3. Verma S, Mazer CD, Yan AT, et al. Effect of Empagliflozin on Left Ventricular Mass in Patients With Type 2 Diabetes Mellitus and Coronary Artery Disease: The EMPA-HEART CardioLink-6 Randomized Clinical Trial. Circulation. 2019;140(21):1693-1702. doi:10.1161/CIRCULATIONAHA.119.042375.

4. 扬玉华, 杨杰孚, 涓, 等. 继发性性中风确诊和疗程专家共识 [J]. 临床心血管病周刊, 2020 年 36 卷 1 期, 1-10 页, ISTIC PKU CSCD, 2020.

5. 武锋超, 马兰象, 蓝庆肃, 韩俊先, 王姣, 姚亚丽.SGLT2 类似物疗程中风的有效性和安全性的网状 Meta 分析 [J]. 中国循证医学周刊,2022,22(03):291-298.

。

拉肚子怎么调理
有哪些治疗干眼症的眼药水
孩子积食
湿气重吃什么排湿最快医生是这么说的
好的绝经医院